Shanghai SynTheAll Pharmaceutical Co., Ltd. sold 53.52 million shares of WUXI XDC (02268) at an average of HKD 73.23 per share on August 31, 2026, involving about HKD 3.92 billion.
Prior to the disposal, Shanghai SynTheAll Pharmaceutical Co., Ltd.'s long position in WUXI XDC was 232.90 million shares, representing 18.36%; following the disposal, the holding changed to 179.38 million shares, with the long position ratio falling to 14.14%.